
What’s new in breast cancer research? – July-August 2025
Breast cancer is the second cancer-related cause of death in women worldwide, therefore it is no

Breast cancer is the second cancer-related cause of death in women worldwide, therefore it is no

Introduction Microphysiological systems (MPS) are fast becoming a cornerstone of FDA-aligned non-clinical strategy, especially when paired

Introduction Organoid and artificial intelligence approaches are central to the FDA’s roadmap for reducing animal use

Introduction Adipose tissue-breast cancer crosstalk is emerging as a key driver of tumor initiation, progression, and

Introduction Following our articles on how breast cancer organoids and breast‑cancer‑on‑chip platforms expand beyond conventional 2D and

3D breast cancer models are rapidly redefining how we investigate the world’s deadliest malignancy in women,

Breast cancer has long been one of the most prevalent and challenging cancers worldwide, demanding constant

Obesity, type 2 diabetes, and non-alcoholic fatty liver disease (NAFLD) remain major global health concerns, yet

Adipose tissue organoid technology is reshaping metabolic research. From scaffold-free spheroids to hydrogel-based 3D adipose tissue

What Does Adipose Tissue Do? Adipose tissue is more than a fat storage site, it’s a